DOI: https://dx.doi.org/10.18203/2349-3933.ijam20223019
Published: 2022-11-23

Risk of progression to overt hypothyroidism in Indian patients with subclinical hypothyroidism: a prospective observational study

Shailendra Kumar Singh, Rina Singh, Santosh Kumar Singh, Mir Asif Iquebal, Sarika Jaiswal, Pradeep Kumar Rai

Abstract


Background: Subclinical hypothyroidism (SCH) is a common endocrine disorder but spontaneous course of SCH in India is lacking. The aim of the study is to determine the spontaneous course of SCH and to identify the risk factors, which enhances the occurrence of overt hypothyroidism (OH).

Method: This is a real world prospective observational study. 58 SCH were followed up six monthly for one year to determine the course of SCH.

Results: After one year of follow up 11 (18.97%) patients progressed to OH. 37 (63.79%) remained in subclinical hypothyroid category. In 10 (17.29%) patients TSH (thyrotropin) normalized. Rate of progression (odds ratio: 4.58; 95% CI: 1.14, 18.28) was significantly more in anti-thyroid peroxidase (TPO) positive group as compared to anti-TPO negative group.

Conclusions: This first data from India clearly shows that SCH has a variable course. Rate of progression to OH is high (18.97%) in Indian SCH patients. In a cohort of 58 patients followed for one year only the presence of anti-TPO antibody was predictive of OH. The initial risk stratification can identify patients with SCH at greatest risk for progression to OH in which treatment is mandatory.


Keywords


SCH, OH, Progression, Anti-TPO antibody

Full Text:

PDF

References


Unnikrishnan AG, Menon UV. Thyroid disorders in India: An epidemiological perspective. Indian J Endocr Metab. 2011;15:78-81.

Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29:76-131.

Singh SK, Singh R, Singh A. Prevalence of thyroid disorder in newly diagnosed Type 2 diabetes mellitus patients: A cross sectional study. J Assoc Physician India. 2021;69(10):11-2.

Nair A, Jayakumari C, Jabbar PK, Jayakumar RV, Raizada N, Gopi A et al. Prevalence and associations of hypothyroidism in Indian patients with type 2 diabetes mellitus. J Thyroid Res. 2018:5386129.

Tunbridge WM, Evered DC, Hall R. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol. 1977;7(6):481-93.

Cooper DS. Subclinical thyroid disease: a clinician’s perspective. Ann Intern Med. 1998;129(2):135-8.

Sawin CT, Chopra D, Azizi F, Mannix JE, Bacharach P. The aging thyroid. Increased prevalence of elevated serum thyrotropin levels in the elderly. JAMA. 1979;242:247-50.

Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526-34.

Zulewski H, Muller B, Exer P, Miserez AR, Staub JJ. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab. 1997;82:771-6.

Lekakis J, Papamichael C, Alevizaki M, Piperingos G, Marafelia P. Flow-mediated, endothelium-dependent vasodilatation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid. 1997;7:411-4.

Tanis BC, Westendorp RGJ, Smelt AHM. Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a re-analysis of intervention studies. Clin Endocrinol. 1996;44:643-9.

Hak AE, Pols HAP, Visser TJ, Drexhage HA, Hofman A, Witteman JCM. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam study. Ann Intern Med. 2000;132:270-78.

Kahaly GJ. Cardiovascular and atherogenic aspects of subclinical hypo-thyroidism. Thyroid. 2000;10:665-79.

Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf). 1991;34:77-83.

Rosenthal MJ, Hunt WC, Garry PJ, Goodwin JS. Thyroid failure in the elderly: microsomal antibodies as discriminant for therapy. JAMA. 1987;258:209-21.

Kabadi UM. Subclinical hypothyroidism: Natural course of the syndrome during a prolonged follow-up study. Arch Intern Med. 1993;153:957-61.

Imaizumi M, Sera N, Ueki I, Horie I, Ando T, Usa T et al. Risk for progression to overt hypothyroidism in an elderly Japanese population with subclinical hypothyroidism. Thyroid. 2011;21(11):1177-82.

Huber G, Staub JJ, Meier C, Mitrache C, Guglielmetti M, Huber P et al. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab. 2002;87:3221-6.

Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43:55-68.

Harjeet A, Sahni D, Jit I, Agrawal. Shape, measurements and weight of the thyroid gland in northwest Indians. Surg Radiol Anat. 2004;26:91-5.

Diez JJ, Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab. 2004;89:4890-7.

Kasagi K, Takahashi N, Inoue G, Honda T, Kawachi Y, Izumi Y. Thyroid function in Japanese adults as assessed by a general health checkup system in relation with thyroid-related antibodies and other clinical parameters. Thyroid. 2009;19:937-44.

Tudor RM, Garrahy A, Woods CP. The prevalence and incidence of thyroid dysfunction in patients with diabetes- a longitudinal follow-up study. Ir J Med Sci. 2020;189(1):171-5

Andersen S, Pedersen KM, Bruun NH, Laurberg P. Narrow individual variations in serum T (4) and T (3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab. 2002;87:1068-72.